Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1999
05/20/1999CA2309162A1 Piperidine derivatives and their use as tachykinin antagonists
05/20/1999CA2309123A1 Stable antiandrogenic gel composition
05/20/1999CA2309121A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999CA2308406A1 Method for reducing mast cell mediated allergic reactions
05/20/1999CA2308361A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999CA2308269A1 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
05/20/1999CA2306155A1 Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
05/20/1999CA2277379A1 Medicine for promoting cicatrization and containing thrombocytes
05/20/1999CA2276276A1 Cancer treatment drug
05/19/1999EP0916727A2 Novel LysS
05/19/1999EP0916673A1 6-Amino purine derivatives having PDE-IV inhibition activity
05/19/1999EP0916672A1 6-Amino purine derivatives having PDE-IV inhibition activity and intermediates
05/19/1999EP0916671A1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them
05/19/1999EP0916666A1 3-alkyloxy-,aryloxy-, or arylalkyloxy-benzo[b]thiophene-2-carboxamides as inhibitors of cell adhesion
05/19/1999EP0916349A2 Method for monitoring cellular oxidative function
05/19/1999EP0916346A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
05/19/1999EP0916344A2 Nef action inhibitor
05/19/1999EP0916340A1 Suppositories
05/19/1999EP0915904A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor
05/19/1999EP0915882A1 1-azoniabicyclo[2.2.1]heptane derivatives and pharmaceutical compositions containing them
05/19/1999EP0915881A1 Pyrroloazepine compounds
05/19/1999EP0915876A1 Tricyclic benzazepine vasopressin antagonists
05/19/1999EP0915875A2 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
05/19/1999EP0915869A1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/19/1999EP0915864A1 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease
05/19/1999EP0915860A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands
05/19/1999EP0915859A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
05/19/1999EP0915856A1 Diphenyl heterocycles as potassium channel modulators
05/19/1999EP0915850A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof
05/19/1999EP0915848A1 1,2-diarylindole as cox-2 inhibitors
05/19/1999EP0915847A1 Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
05/19/1999EP0915843A1 Azetidinone derivatives for the treatment of atheroscleroses
05/19/1999EP0915842A1 Nitrate esters and their use for neurological conditions
05/19/1999EP0915825A2 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
05/19/1999EP0915710A2 Stable radioiodine conjugates and methods for their synthesis
05/19/1999EP0915706A1 Screening methods for compounds useful in the regulation of body weight
05/19/1999EP0915702A2 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
05/19/1999EP0915701A1 Fast-dissolving galanthamine hydrobromide tablet
05/19/1999EP0915700A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
05/19/1999EP0915698A1 Therapeutic treatment for vegf related diseases
05/19/1999EP0752986B1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
05/19/1999EP0745596B1 Heteroaromatic oxazole compounds and use thereof
05/19/1999EP0607346B1 Collagen constructs
05/19/1999CN1217027A Parapoxviruses contg. foreign DNA, their prodn. and their use in vacciens
05/19/1999CN1217024A Chemokine alpha 2
05/19/1999CN1216993A Alkyl-4-silyl-phenols and esters thereof as anti-atherosclerotic agent
05/19/1999CN1216980A Triaryl compounds
05/19/1999CN1216921A Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
05/19/1999CN1216762A 2-(arylphenyl) amino-imidazoline derivatives
05/19/1999CN1216707A Medicine for tonifying the kidney and health-care contg. air bladder of fish
05/19/1999CN1043424C Quaternary nitrogen contg. phosphonate compounds, pharmaceutical compositions and pharmaceutical use
05/18/1999US5905149 Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors
05/18/1999US5905080 Central nervous system, psychological, eating disorders; cognition activators, parkinson*s disease
05/18/1999US5905078 Treatment of neurohormonal imbalance
05/18/1999US5904931 Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
05/18/1999US5904920 Regulation of systemic immune responses utilizing cytokines and antigens
05/18/1999CA2158952C 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
05/14/1999WO1999023227A2 Hyaluronan synthase gene and uses thereof
05/14/1999WO1999023109A2 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
05/14/1999WO1999023106A1 Caspase-14 polypeptides
05/14/1999WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth
05/14/1999WO1999023096A1 Phthalocyanine analogs
05/14/1999WO1999023078A2 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists
05/14/1999WO1999023077A1 Indazole bioisostere replacement of catechol in therapeutically active compounds
05/14/1999WO1999023063A1 Substituted anilides
05/14/1999WO1999022760A1 Method and compositions for inhibiting angiogenesis and treating cancer
05/14/1999WO1999022752A1 Composition and method for increasing insulin activity
05/14/1999WO1999022734A1 Novel metal complexes
05/14/1999WO1999022733A1 Novel metal complexes
05/14/1999WO1999022732A1 Novel metal complexes
05/14/1999WO1999022728A1 Methods and compositions for regulation of 5-alpha reductase activity
05/14/1999WO1999022720A2 Selective cyclooxygenase-2 inhibitors against premature labor
05/14/1999WO1999022713A1 Sustained release ophthalmic compositions containing water soluble medicaments
05/14/1999WO1999012561A3 FRACTURE HEALING USING PTHrP ANALOGS
05/14/1999WO1999010338A3 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
05/14/1999WO1999007692A3 New epothilone derivatives, method for producing same and their pharmaceutical use
05/14/1999WO1999007352A3 Method for promoting expression of ldl receptor gene
05/14/1999WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists
05/14/1999WO1999004752A3 Methods for treating skin pigmentation
05/14/1999WO1999001764A3 METHOD FOR DETERMINING GnRH RECEPTORS
05/14/1999WO1998058915A3 Pyrimidin-2,4,6-trion derivatives and their use as metalloprotease-inhibitors
05/14/1999WO1998053838A3 A soluble laminin receptor precursor and methods to inhibit its interactions
05/14/1999WO1998051289A3 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
05/14/1999WO1998014593A9 Human telomerase catalytic subunit
05/14/1999WO1997035539A3 Arylamino fused pyridines and pyrimidines
05/14/1999CA2309150A1 Indazole bioisostere replacement of catechol in therapeutically active compounds
05/14/1999CA2308639A1 Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor
05/14/1999CA2308438A1 Method and compositions for inhibiting angiogenesis and treating cancer
05/14/1999CA2308317A1 Novel metal complexes
05/14/1999CA2308316A1 Novel metal complexes
05/14/1999CA2308135A1 Novel metal complexes
05/14/1999CA2308112A1 Caspase-14 polypeptides
05/14/1999CA2307805A1 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
05/14/1999CA2307770A1 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists
05/14/1999CA2302379A1 Sustained release ophthalmic compositions containing water soluble medicaments
05/12/1999EP0915168A1 Process for producing maturation bone morphogenetic protein
05/12/1999EP0915088A1 D-Proline derivatives
05/12/1999EP0915087A2 Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them
1 ... 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 ... 1564